ESTRO shared on X: .
“Discover the latest lung cancer research at ESTRO 24: highlights include the ETOP CHESS trial, SAKK 16/18 study, START-NEW-ERA outcomes, SYSTEMS-2 pain control, high-dose re-irradiation insights, and a stage III NSCLC trial on hypofractionation.”
Source: ESTRO/X